PMID- 32844230 OWN - NLM STAT- MEDLINE DCOM- 20211115 LR - 20240216 IS - 1477-4054 (Electronic) IS - 1467-5463 (Print) IS - 1467-5463 (Linking) VI - 22 IP - 3 DP - 2021 May 20 TI - The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer. LID - 10.1093/bib/bbaa191 [doi] LID - bbaa191 AB - Alternative polyadenylation (APA) in breast tumor samples results in the removal/addition of cis-regulatory elements such as microRNA (miRNA) target sites in the 3'-untranslated region (3'-UTRs) of genes. Although previous computational APA studies focused on a subset of genes strongly affected by APA (APA genes), we identify miRNAs of which widespread APA events collectively increase or decrease the number of target sites [probabilistic inference of microRNA target site modification through APA (PRIMATA-APA)]. Using PRIMATA-APA on the cancer genome atlas (TCGA) breast cancer data, we found that the global APA events change the number of the target sites of particular microRNAs [target sites modified miRNA (tamoMiRNA)] enriched for cancer development and treatments. We also found that when knockdown (KD) of NUDT21 in HeLa cells induces a different set of widespread 3'-UTR shortening than TCGA breast cancer data, it changes the target sites of the common tamoMiRNAs. Since the NUDT21 KD experiment previously demonstrated the tumorigenic role of APA events in a miRNA dependent fashion, this result suggests that the APA-initiated tumorigenesis is attributable to the miRNA target site changes, not the APA events themselves. Further, we found that the miRNA target site changes identify tumor cell proliferation and immune cell infiltration to the tumor microenvironment better than the miRNA expression levels or the APA events themselves. Altogether, our computational analyses provide a proof-of-concept demonstration that the miRNA target site information indicates the effect of global APA events with a potential as predictive biomarker. CI - (c) The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. FAU - Kim, Soyeon AU - Kim S AD - Department of Pediatrics, University of Pittsburgh Medical Center and in Division of Pulmonary Medicine, Children's Hospital of Pittsburgh of UPMC. FAU - Bai, YuLong AU - Bai Y AD - Department of Human Genetics in the Graduate School of Public Health, University of Pittsburgh. FAU - Fan, Zhenjiang AU - Fan Z AD - Department of Computer Science, University of Pittsburgh. FAU - Diergaarde, Brenda AU - Diergaarde B AD - Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh. FAU - Tseng, George C AU - Tseng GC AD - Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh. FAU - Park, Hyun Jung AU - Park HJ AUID- ORCID: 0000-0002-8324-2624 AD - Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh. LA - eng GR - P30 CA047904/CA/NCI NIH HHS/United States GR - UL1 TR001857/TR/NCATS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - England TA - Brief Bioinform JT - Briefings in bioinformatics JID - 100912837 RN - 0 (3' Untranslated Regions) RN - 0 (Cleavage And Polyadenylation Specificity Factor) RN - 0 (MicroRNAs) RN - 0 (Nudt21 protein, human) SB - IM MH - 3' Untranslated Regions/*genetics MH - Algorithms MH - Binding Sites/genetics MH - Breast Neoplasms/*genetics/metabolism MH - Cell Proliferation/genetics MH - Cleavage And Polyadenylation Specificity Factor/genetics/metabolism MH - Gene Expression Regulation, Neoplastic MH - HeLa Cells MH - Humans MH - MicroRNAs/*genetics MH - Models, Genetic MH - Polyadenylation/*genetics MH - RNA-Seq/methods MH - Tumor Escape/*genetics MH - Tumor Microenvironment/genetics PMC - PMC8138879 OTO - NOTNLM OT - cancer OT - microRNA OT - posttranscriptional regulation OT - tumor heterogeneity EDAT- 2020/08/28 06:00 MHDA- 2021/11/16 06:00 PMCR- 2021/08/26 CRDT- 2020/08/27 06:00 PHST- 2020/05/21 00:00 [received] PHST- 2020/07/10 00:00 [revised] PHST- 2020/07/28 00:00 [accepted] PHST- 2020/08/28 06:00 [pubmed] PHST- 2021/11/16 06:00 [medline] PHST- 2020/08/27 06:00 [entrez] PHST- 2021/08/26 00:00 [pmc-release] AID - 5897059 [pii] AID - bbaa191 [pii] AID - 10.1093/bib/bbaa191 [doi] PST - ppublish SO - Brief Bioinform. 2021 May 20;22(3):bbaa191. doi: 10.1093/bib/bbaa191.